nodes	percent_of_prediction	percent_of_DWPC	metapath
Mupirocin—IARS—respiratory system—chronic obstructive pulmonary disease	0.0574	0.209	CbGeAlD
Mupirocin—IARS—connective tissue—chronic obstructive pulmonary disease	0.0505	0.184	CbGeAlD
Mupirocin—IARS—bronchus—chronic obstructive pulmonary disease	0.0472	0.172	CbGeAlD
Mupirocin—IARS—smooth muscle tissue—chronic obstructive pulmonary disease	0.0462	0.169	CbGeAlD
Mupirocin—IARS—trachea—chronic obstructive pulmonary disease	0.0424	0.155	CbGeAlD
Mupirocin—IARS—lung—chronic obstructive pulmonary disease	0.0305	0.111	CbGeAlD
Mupirocin—Ulcerative stomatitis—Tiotropium—chronic obstructive pulmonary disease	0.0278	0.0383	CcSEcCtD
Mupirocin—Dermatitis contact—Aminophylline—chronic obstructive pulmonary disease	0.0135	0.0185	CcSEcCtD
Mupirocin—Mouth ulceration—Tiotropium—chronic obstructive pulmonary disease	0.0116	0.016	CcSEcCtD
Mupirocin—Dermatitis exfoliative—Aminophylline—chronic obstructive pulmonary disease	0.0105	0.0144	CcSEcCtD
Mupirocin—Rhinitis—Roflumilast—chronic obstructive pulmonary disease	0.0103	0.0142	CcSEcCtD
Mupirocin—Dermatitis contact—Arformoterol—chronic obstructive pulmonary disease	0.0102	0.0141	CcSEcCtD
Mupirocin—Dermatitis contact—Formoterol—chronic obstructive pulmonary disease	0.0102	0.0141	CcSEcCtD
Mupirocin—Immune system disorder—Roflumilast—chronic obstructive pulmonary disease	0.00926	0.0128	CcSEcCtD
Mupirocin—Dysgeusia—Roflumilast—chronic obstructive pulmonary disease	0.00874	0.012	CcSEcCtD
Mupirocin—Ear pain—Montelukast—chronic obstructive pulmonary disease	0.00864	0.0119	CcSEcCtD
Mupirocin—Dry skin—Tiotropium—chronic obstructive pulmonary disease	0.00854	0.0118	CcSEcCtD
Mupirocin—Ear pain—Salbutamol—chronic obstructive pulmonary disease	0.00833	0.0115	CcSEcCtD
Mupirocin—Eczema—Montelukast—chronic obstructive pulmonary disease	0.0082	0.0113	CcSEcCtD
Mupirocin—Angioedema—Roflumilast—chronic obstructive pulmonary disease	0.00816	0.0112	CcSEcCtD
Mupirocin—Eczema—Salbutamol—chronic obstructive pulmonary disease	0.0079	0.0109	CcSEcCtD
Mupirocin—Unspecified disorder of skin and subcutaneous tissue—Roflumilast—chronic obstructive pulmonary disease	0.00755	0.0104	CcSEcCtD
Mupirocin—Skin disorder—Roflumilast—chronic obstructive pulmonary disease	0.00708	0.00975	CcSEcCtD
Mupirocin—Stinging—Prednisolone—chronic obstructive pulmonary disease	0.00693	0.00955	CcSEcCtD
Mupirocin—Dry skin—Arformoterol—chronic obstructive pulmonary disease	0.0069	0.0095	CcSEcCtD
Mupirocin—Dry skin—Formoterol—chronic obstructive pulmonary disease	0.0069	0.0095	CcSEcCtD
Mupirocin—Epistaxis—Tiotropium—chronic obstructive pulmonary disease	0.00678	0.00934	CcSEcCtD
Mupirocin—Rhinitis—Tiotropium—chronic obstructive pulmonary disease	0.00646	0.00891	CcSEcCtD
Mupirocin—Pharyngitis—Tiotropium—chronic obstructive pulmonary disease	0.0064	0.00882	CcSEcCtD
Mupirocin—Gastrointestinal pain—Roflumilast—chronic obstructive pulmonary disease	0.00596	0.00821	CcSEcCtD
Mupirocin—Immune system disorder—Tiotropium—chronic obstructive pulmonary disease	0.00582	0.00803	CcSEcCtD
Mupirocin—Urticaria—Roflumilast—chronic obstructive pulmonary disease	0.00579	0.00797	CcSEcCtD
Mupirocin—Abdominal pain—Roflumilast—chronic obstructive pulmonary disease	0.00576	0.00794	CcSEcCtD
Mupirocin—Hypersensitivity—Roflumilast—chronic obstructive pulmonary disease	0.00537	0.0074	CcSEcCtD
Mupirocin—Epistaxis—Montelukast—chronic obstructive pulmonary disease	0.00536	0.00738	CcSEcCtD
Mupirocin—Rhinitis—Formoterol—chronic obstructive pulmonary disease	0.00522	0.00719	CcSEcCtD
Mupirocin—Rhinitis—Arformoterol—chronic obstructive pulmonary disease	0.00522	0.00719	CcSEcCtD
Mupirocin—Pharyngitis—Arformoterol—chronic obstructive pulmonary disease	0.00517	0.00712	CcSEcCtD
Mupirocin—Pharyngitis—Formoterol—chronic obstructive pulmonary disease	0.00517	0.00712	CcSEcCtD
Mupirocin—Epistaxis—Salbutamol—chronic obstructive pulmonary disease	0.00516	0.00711	CcSEcCtD
Mupirocin—Angioedema—Tiotropium—chronic obstructive pulmonary disease	0.00513	0.00707	CcSEcCtD
Mupirocin—Rhinitis—Montelukast—chronic obstructive pulmonary disease	0.00511	0.00704	CcSEcCtD
Mupirocin—Pharyngitis—Montelukast—chronic obstructive pulmonary disease	0.00506	0.00697	CcSEcCtD
Mupirocin—Diarrhoea—Roflumilast—chronic obstructive pulmonary disease	0.00498	0.00687	CcSEcCtD
Mupirocin—Haemoglobin—Salbutamol—chronic obstructive pulmonary disease	0.00494	0.00681	CcSEcCtD
Mupirocin—Rhinitis—Salbutamol—chronic obstructive pulmonary disease	0.00493	0.00679	CcSEcCtD
Mupirocin—Haemorrhage—Salbutamol—chronic obstructive pulmonary disease	0.00491	0.00677	CcSEcCtD
Mupirocin—Cough—Tiotropium—chronic obstructive pulmonary disease	0.0049	0.00675	CcSEcCtD
Mupirocin—Pharyngitis—Salbutamol—chronic obstructive pulmonary disease	0.00488	0.00672	CcSEcCtD
Mupirocin—Anaphylactic shock—Aminophylline—chronic obstructive pulmonary disease	0.00486	0.00669	CcSEcCtD
Mupirocin—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.00482	0.00664	CcSEcCtD
Mupirocin—Unspecified disorder of skin and subcutaneous tissue—Tiotropium—chronic obstructive pulmonary disease	0.00475	0.00654	CcSEcCtD
Mupirocin—Immune system disorder—Formoterol—chronic obstructive pulmonary disease	0.0047	0.00648	CcSEcCtD
Mupirocin—Immune system disorder—Arformoterol—chronic obstructive pulmonary disease	0.0047	0.00648	CcSEcCtD
Mupirocin—Dry mouth—Tiotropium—chronic obstructive pulmonary disease	0.00467	0.00644	CcSEcCtD
Mupirocin—Immune system disorder—Montelukast—chronic obstructive pulmonary disease	0.0046	0.00634	CcSEcCtD
Mupirocin—Rash—Roflumilast—chronic obstructive pulmonary disease	0.00459	0.00633	CcSEcCtD
Mupirocin—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.00459	0.00632	CcSEcCtD
Mupirocin—Headache—Roflumilast—chronic obstructive pulmonary disease	0.00456	0.00629	CcSEcCtD
Mupirocin—Skin disorder—Tiotropium—chronic obstructive pulmonary disease	0.00445	0.00613	CcSEcCtD
Mupirocin—Immune system disorder—Salbutamol—chronic obstructive pulmonary disease	0.00444	0.00612	CcSEcCtD
Mupirocin—Dysgeusia—Formoterol—chronic obstructive pulmonary disease	0.00444	0.00611	CcSEcCtD
Mupirocin—Dysgeusia—Arformoterol—chronic obstructive pulmonary disease	0.00444	0.00611	CcSEcCtD
Mupirocin—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.00433	0.00596	CcSEcCtD
Mupirocin—Dysgeusia—Salbutamol—chronic obstructive pulmonary disease	0.00419	0.00577	CcSEcCtD
Mupirocin—Angioedema—Formoterol—chronic obstructive pulmonary disease	0.00414	0.0057	CcSEcCtD
Mupirocin—Angioedema—Arformoterol—chronic obstructive pulmonary disease	0.00414	0.0057	CcSEcCtD
Mupirocin—Angioedema—Montelukast—chronic obstructive pulmonary disease	0.00405	0.00559	CcSEcCtD
Mupirocin—Gastrointestinal pain—Aminophylline—chronic obstructive pulmonary disease	0.00397	0.00547	CcSEcCtD
Mupirocin—Cough—Formoterol—chronic obstructive pulmonary disease	0.00395	0.00545	CcSEcCtD
Mupirocin—Cough—Arformoterol—chronic obstructive pulmonary disease	0.00395	0.00545	CcSEcCtD
Mupirocin—Angioedema—Salbutamol—chronic obstructive pulmonary disease	0.00391	0.00539	CcSEcCtD
Mupirocin—Cough—Montelukast—chronic obstructive pulmonary disease	0.00387	0.00534	CcSEcCtD
Mupirocin—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.00386	0.00532	CcSEcCtD
Mupirocin—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.00384	0.00529	CcSEcCtD
Mupirocin—Unspecified disorder of skin and subcutaneous tissue—Arformoterol—chronic obstructive pulmonary disease	0.00383	0.00528	CcSEcCtD
Mupirocin—Unspecified disorder of skin and subcutaneous tissue—Formoterol—chronic obstructive pulmonary disease	0.00383	0.00528	CcSEcCtD
Mupirocin—Dry mouth—Formoterol—chronic obstructive pulmonary disease	0.00377	0.0052	CcSEcCtD
Mupirocin—Dry mouth—Arformoterol—chronic obstructive pulmonary disease	0.00377	0.0052	CcSEcCtD
Mupirocin—Unspecified disorder of skin and subcutaneous tissue—Montelukast—chronic obstructive pulmonary disease	0.00375	0.00517	CcSEcCtD
Mupirocin—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.00375	0.00516	CcSEcCtD
Mupirocin—Dry skin—Prednisolone—chronic obstructive pulmonary disease	0.00373	0.00515	CcSEcCtD
Mupirocin—Cough—Salbutamol—chronic obstructive pulmonary disease	0.00373	0.00514	CcSEcCtD
Mupirocin—Anaphylactic shock—Formoterol—chronic obstructive pulmonary disease	0.0037	0.00509	CcSEcCtD
Mupirocin—Anaphylactic shock—Arformoterol—chronic obstructive pulmonary disease	0.0037	0.00509	CcSEcCtD
Mupirocin—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.00364	0.00502	CcSEcCtD
Mupirocin—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.00362	0.00499	CcSEcCtD
Mupirocin—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.00362	0.00499	CcSEcCtD
Mupirocin—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.00359	0.00495	CcSEcCtD
Mupirocin—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.00359	0.00495	CcSEcCtD
Mupirocin—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.00358	0.00493	CcSEcCtD
Mupirocin—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.00356	0.00491	CcSEcCtD
Mupirocin—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.00352	0.00485	CcSEcCtD
Mupirocin—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.00349	0.00481	CcSEcCtD
Mupirocin—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.00344	0.00474	CcSEcCtD
Mupirocin—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.00339	0.00467	CcSEcCtD
Mupirocin—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.00338	0.00465	CcSEcCtD
Mupirocin—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.00332	0.00458	CcSEcCtD
Mupirocin—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.00324	0.00447	CcSEcCtD
Mupirocin—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.00321	0.00443	CcSEcCtD
Mupirocin—Pain—Formoterol—chronic obstructive pulmonary disease	0.00316	0.00436	CcSEcCtD
Mupirocin—Pain—Arformoterol—chronic obstructive pulmonary disease	0.00316	0.00436	CcSEcCtD
Mupirocin—Pain—Montelukast—chronic obstructive pulmonary disease	0.0031	0.00427	CcSEcCtD
Mupirocin—Rash—Aminophylline—chronic obstructive pulmonary disease	0.00306	0.00422	CcSEcCtD
Mupirocin—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.00306	0.00422	CcSEcCtD
Mupirocin—Headache—Aminophylline—chronic obstructive pulmonary disease	0.00304	0.00419	CcSEcCtD
Mupirocin—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.00303	0.00417	CcSEcCtD
Mupirocin—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.00302	0.00417	CcSEcCtD
Mupirocin—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.00302	0.00417	CcSEcCtD
Mupirocin—Pain—Salbutamol—chronic obstructive pulmonary disease	0.00299	0.00411	CcSEcCtD
Mupirocin—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.00296	0.00408	CcSEcCtD
Mupirocin—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.00294	0.00405	CcSEcCtD
Mupirocin—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.00294	0.00405	CcSEcCtD
Mupirocin—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.00292	0.00403	CcSEcCtD
Mupirocin—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.00292	0.00403	CcSEcCtD
Mupirocin—Rash—Tiotropium—chronic obstructive pulmonary disease	0.00289	0.00398	CcSEcCtD
Mupirocin—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.00289	0.00398	CcSEcCtD
Mupirocin—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.00289	0.00398	CcSEcCtD
Mupirocin—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.00288	0.00396	CcSEcCtD
Mupirocin—Headache—Tiotropium—chronic obstructive pulmonary disease	0.00287	0.00395	CcSEcCtD
Mupirocin—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.00286	0.00394	CcSEcCtD
Mupirocin—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.00285	0.00393	CcSEcCtD
Mupirocin—Haemoglobin—Prednisolone—chronic obstructive pulmonary disease	0.00283	0.0039	CcSEcCtD
Mupirocin—Haemorrhage—Prednisolone—chronic obstructive pulmonary disease	0.00282	0.00388	CcSEcCtD
Mupirocin—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.00277	0.00382	CcSEcCtD
Mupirocin—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.00276	0.0038	CcSEcCtD
Mupirocin—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.00272	0.00375	CcSEcCtD
Mupirocin—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.00272	0.00375	CcSEcCtD
Mupirocin—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.00272	0.00375	CcSEcCtD
Mupirocin—Dry skin—Prednisone—chronic obstructive pulmonary disease	0.00271	0.00374	CcSEcCtD
Mupirocin—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.00267	0.00368	CcSEcCtD
Mupirocin—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.00262	0.0036	CcSEcCtD
Mupirocin—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.00262	0.0036	CcSEcCtD
Mupirocin—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.00257	0.00354	CcSEcCtD
Mupirocin—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.00256	0.00353	CcSEcCtD
Mupirocin—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.00253	0.00349	CcSEcCtD
Mupirocin—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.00253	0.00349	CcSEcCtD
Mupirocin—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.00248	0.00341	CcSEcCtD
Mupirocin—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.00247	0.0034	CcSEcCtD
Mupirocin—Erythema—Prednisolone—chronic obstructive pulmonary disease	0.00245	0.00338	CcSEcCtD
Mupirocin—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.00245	0.00337	CcSEcCtD
Mupirocin—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.00245	0.00337	CcSEcCtD
Mupirocin—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.00239	0.0033	CcSEcCtD
Mupirocin—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.00239	0.00329	CcSEcCtD
Mupirocin—Rash—Formoterol—chronic obstructive pulmonary disease	0.00233	0.00321	CcSEcCtD
Mupirocin—Rash—Arformoterol—chronic obstructive pulmonary disease	0.00233	0.00321	CcSEcCtD
Mupirocin—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.00233	0.00321	CcSEcCtD
Mupirocin—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.00233	0.00321	CcSEcCtD
Mupirocin—Headache—Formoterol—chronic obstructive pulmonary disease	0.00232	0.00319	CcSEcCtD
Mupirocin—Headache—Arformoterol—chronic obstructive pulmonary disease	0.00232	0.00319	CcSEcCtD
Mupirocin—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.00231	0.00318	CcSEcCtD
Mupirocin—Rash—Montelukast—chronic obstructive pulmonary disease	0.00228	0.00315	CcSEcCtD
Mupirocin—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.00228	0.00314	CcSEcCtD
Mupirocin—Headache—Montelukast—chronic obstructive pulmonary disease	0.00227	0.00313	CcSEcCtD
Mupirocin—Angioedema—Prednisolone—chronic obstructive pulmonary disease	0.00224	0.00309	CcSEcCtD
Mupirocin—Rash—Salbutamol—chronic obstructive pulmonary disease	0.0022	0.00303	CcSEcCtD
Mupirocin—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.0022	0.00303	CcSEcCtD
Mupirocin—Nausea—Formoterol—chronic obstructive pulmonary disease	0.0022	0.00303	CcSEcCtD
Mupirocin—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.0022	0.00303	CcSEcCtD
Mupirocin—Headache—Salbutamol—chronic obstructive pulmonary disease	0.00219	0.00301	CcSEcCtD
Mupirocin—Nausea—Montelukast—chronic obstructive pulmonary disease	0.00215	0.00296	CcSEcCtD
Mupirocin—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.00207	0.00286	CcSEcCtD
Mupirocin—Haemoglobin—Prednisone—chronic obstructive pulmonary disease	0.00206	0.00284	CcSEcCtD
Mupirocin—Haemorrhage—Prednisone—chronic obstructive pulmonary disease	0.00205	0.00282	CcSEcCtD
Mupirocin—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	0.002	0.00276	CcSEcCtD
Mupirocin—Immune system disorder—Prednisone—chronic obstructive pulmonary disease	0.00185	0.00255	CcSEcCtD
Mupirocin—Erythema—Prednisone—chronic obstructive pulmonary disease	0.00178	0.00246	CcSEcCtD
Mupirocin—Pain—Prednisolone—chronic obstructive pulmonary disease	0.00171	0.00236	CcSEcCtD
Mupirocin—Angioedema—Prednisone—chronic obstructive pulmonary disease	0.00163	0.00224	CcSEcCtD
Mupirocin—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.00159	0.00219	CcSEcCtD
Mupirocin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	0.00151	0.00208	CcSEcCtD
Mupirocin—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.00148	0.00203	CcSEcCtD
Mupirocin—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	0.00146	0.002	CcSEcCtD
Mupirocin—Skin disorder—Prednisone—chronic obstructive pulmonary disease	0.00141	0.00195	CcSEcCtD
Mupirocin—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.00132	0.00182	CcSEcCtD
Mupirocin—Rash—Prednisolone—chronic obstructive pulmonary disease	0.00126	0.00174	CcSEcCtD
Mupirocin—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.00126	0.00174	CcSEcCtD
Mupirocin—Headache—Prednisolone—chronic obstructive pulmonary disease	0.00125	0.00173	CcSEcCtD
Mupirocin—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	0.00119	0.00164	CcSEcCtD
Mupirocin—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.00119	0.00164	CcSEcCtD
Mupirocin—Urticaria—Prednisone—chronic obstructive pulmonary disease	0.00116	0.00159	CcSEcCtD
Mupirocin—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	0.00115	0.00158	CcSEcCtD
Mupirocin—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.00107	0.00148	CcSEcCtD
Mupirocin—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.00103	0.00142	CcSEcCtD
Mupirocin—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.000996	0.00137	CcSEcCtD
Mupirocin—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.000962	0.00133	CcSEcCtD
Mupirocin—Rash—Prednisone—chronic obstructive pulmonary disease	0.000917	0.00126	CcSEcCtD
Mupirocin—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.000917	0.00126	CcSEcCtD
Mupirocin—Headache—Prednisone—chronic obstructive pulmonary disease	0.000912	0.00126	CcSEcCtD
Mupirocin—Nausea—Prednisone—chronic obstructive pulmonary disease	0.000864	0.00119	CcSEcCtD
